These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

233 related articles for article (PubMed ID: 9816237)

  • 21. Expression of transforming growth factor alpha antisense mRNA inhibits the estrogen-induced production of TGF alpha and estrogen-induced proliferation of estrogen-responsive human breast cancer cells.
    Kenney NJ; Saeki T; Gottardis M; Kim N; Garcia-Morales P; Martin MB; Normanno N; Ciardiello F; Day A; Cutler ML
    J Cell Physiol; 1993 Sep; 156(3):497-514. PubMed ID: 8360257
    [TBL] [Abstract][Full Text] [Related]  

  • 22. The novel use of the human nasal epithelial cell line RPMI 2650 as an in vitro model to study the influence of allergens and cytokines on transforming growth factor-beta gene expression and protein release.
    Salib RJ; Lau LC; Howarth PH
    Clin Exp Allergy; 2005 Jun; 35(6):811-9. PubMed ID: 15969674
    [TBL] [Abstract][Full Text] [Related]  

  • 23. TNF-alpha, PDGF, and TGF-beta(1) expression by primary mouse bronchiolar-alveolar epithelial and mesenchymal cells: tnf-alpha induces TGF-beta(1).
    Warshamana GS; Corti M; Brody AR
    Exp Mol Pathol; 2001 Aug; 71(1):13-33. PubMed ID: 11502094
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Transforming growth factor beta 1 can induce estrogen-independent tumorigenicity of human breast cancer cells in athymic mice.
    Arteaga CL; Carty-Dugger T; Moses HL; Hurd SD; Pietenpol JA
    Cell Growth Differ; 1993 Mar; 4(3):193-201. PubMed ID: 8466857
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Identification of a protein factor secreted by 3T3-L1 preadipocytes inhibitory for the human MCF-7 breast cancer cell line.
    Johnston PG; Rondinone CM; Voeller D; Allegra CJ
    Cancer Res; 1992 Dec; 52(24):6860-5. PubMed ID: 1458474
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Transforming growth factor-beta synthesis by human peritoneal mesothelial cells. Induction by interleukin-1.
    Offner FA; Feichtinger H; Stadlmann S; Obrist P; Marth C; Klingler P; Grage B; Schmahl M; Knabbe C
    Am J Pathol; 1996 May; 148(5):1679-88. PubMed ID: 8623935
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Selective formation of tumor necrosis factor-alpha (TNF) degradation products contributes to TNF mediated cytotoxicity.
    Fruehauf JP; Sinha BK
    Oncol Res; 1992; 4(3):91-101. PubMed ID: 1319775
    [TBL] [Abstract][Full Text] [Related]  

  • 28. RRR-alpha-tocopheryl succinate enhances TGF-beta 1, -beta 2, and -beta 3 and TGF-beta R-II expression by human MDA-MB-435 breast cancer cells.
    Charpentier A; Simmons-Menchaca M; Yu W; Zhao B; Qian M; Heim K; Sanders BG; Kline K
    Nutr Cancer; 1996; 26(2):237-50. PubMed ID: 8875561
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Comparative study of human breast carcinoma MCF-7 cells differing in their resistance to doxorubicin: effect of ionizing radiation on apoptosis and TGF-beta production.
    Chorna I; Bilyy R; Datsyuk L; Stoika R
    Exp Oncol; 2004 Jun; 26(2):111-7. PubMed ID: 15273662
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Effect of anticancer drugs on production of transforming growth factor and expression of p53 AND Bcl-2 proteins by MCF-7 and T47D cell lines of human breast carcinoma.
    Stoika RS; Yakymovych IA; Kashchak NI; Boyko MM; Korynevska AV; Klyuchyvska OY; Shafranska GI; Yakymovych MY; Zhylchuk VY; Kudryavets YY; Vorontsova AL
    Exp Oncol; 2008 Mar; 30(1):35-41. PubMed ID: 18438339
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Desensitization of melanoma cells to autocrine TGF-beta isoforms.
    Krasagakis K; Krüger-Krasagakes S; Fimmel S; Eberle J; Thölke D; von der Ohe M; Mansmann U; Orfanos CE
    J Cell Physiol; 1999 Feb; 178(2):179-87. PubMed ID: 10048582
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Up-regulation of transforming growth factor alpha expression by transforming growth factor beta 1, epidermal growth factor, and N,N-dimethylformamide in human colon carcinoma cells.
    Zipfel PA; Ziober BL; Morris SL; Mulder KM
    Cell Growth Differ; 1993 Aug; 4(8):637-45. PubMed ID: 8398905
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Autocrine transforming growth factor-beta 1 and beta 2 expression is increased by cell crowding and quiescence in colon carcinoma cells.
    Sun L; Wu S; Coleman K; Fields KC; Humphrey LE; Brattain MG
    Exp Cell Res; 1994 Sep; 214(1):215-24. PubMed ID: 8082724
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Protein kinase C beta enhances growth and expression of cyclin D1 in human breast cancer cells.
    Li H; Weinstein IB
    Cancer Res; 2006 Dec; 66(23):11399-408. PubMed ID: 17145886
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Effects of tamoxifen on transcriptional level of transforming growth factor beta (TGF-beta) isoforms 1 and 2 in tumor tissue during primary treatment of patients with breast cancer.
    Brandt S; Kopp A; Grage B; Knabbe C
    Anticancer Res; 2003; 23(1A):223-9. PubMed ID: 12680217
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Breast cyst fluids increase the proliferation of breast cell lines in correlation with their hormone and growth factor concentration.
    Enriori PJ; Vázquez SM; Chiauzzi V; Pérez C; Fischer CR; Gori JR; Etkin AE; Charreau E; Calandra RS; Lüthy IA
    Clin Endocrinol (Oxf); 2006 Jan; 64(1):20-8. PubMed ID: 16402924
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Activated alpha 2-macroglobulin reverses the immunosuppressive activity in human breast cancer cell-conditioned medium by selectively neutralizing transforming growth factor-beta in the presence of interleukin-2.
    Harthun NL; Weaver AM; Brinckerhoff LH; Deacon DH; Gonias SL; Slingluff CL
    J Immunother; 1998 Mar; 21(2):85-94. PubMed ID: 9551359
    [TBL] [Abstract][Full Text] [Related]  

  • 38. The growth inhibition of human breast cancer cells by a novel synthetic progestin involves the induction of transforming growth factor beta.
    Colletta AA; Wakefield LM; Howell FV; Danielpour D; Baum M; Sporn MB
    J Clin Invest; 1991 Jan; 87(1):277-83. PubMed ID: 1985102
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Differential mechanisms of plasminogen activator inhibitor-1 gene activation by transforming growth factor-beta and tumor necrosis factor-alpha in endothelial cells.
    Chen YQ; Sloan-Lancaster J; Berg DT; Richardson MA; Grinnell B; Tseng-Crank J
    Thromb Haemost; 2001 Dec; 86(6):1563-72. PubMed ID: 11776328
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Transforming growth factor-beta protection of cancer cells against tumor necrosis factor cytotoxicity is counteracted by hyaluronidase (review).
    Chang NS
    Int J Mol Med; 1998 Dec; 2(6):653-9. PubMed ID: 9850732
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.